Skip to content
← Back to this collection

PUBLICATIONS · 20624787

Efficacy of high-dose methotrexate, ifosfamide, etoposide and dexamethasone salvage therapy for recurrent or refractory childhood malignant lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2011 Feb
First author
Sandlund JT

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Sandlund JT
      type
      Author
    2. name
      Pui CH
      type
      Author
    3. name
      Mahmoud H
      type
      Author
    4. name
      Zhou Y
      type
      Author
    5. name
      Lowe E
      type
      Author
    6. name
      Kaste S
      type
      Author
    7. name
      Kun LE
      type
      Author
    8. name
      Krasin MJ
      type
      Author
    9. name
      Onciu M
      type
      Author
    10. name
      Behm FG
      type
      Author
    11. name
      Ribeiro RC
      type
      Author
    12. name
      Razzouk BI
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Sandlund JT
      type
      Author
    2. name
      Pui CH
      type
      Author
    3. name
      Mahmoud H
      type
      Author
    4. name
      Zhou Y
      type
      Author
    5. name
      Lowe E
      type
      Author
    6. name
      Kaste S
      type
      Author
    7. name
      Kun LE
      type
      Author
    8. name
      Krasin MJ
      type
      Author
    9. name
      Onciu M
      type
      Author
    10. name
      Behm FG
      type
      Author
    11. name
      Ribeiro RC
      type
      Author
    12. name
      Razzouk BI
      type
      Author
    bibliography ids
    1. nci-bib-e33757fa58b9fe1a1e666320
    book metadata
    content sha256
    b96f9464f0ebe3440b8ad2367a0458f03746e616ec01ab6ed95a6d5c90380293
    document type
    citation
    dois
    1. 10.1093/annonc/mdq348
    electronic publication date
    display
    2010 Jul 12
    precision
    day
    year
    2010
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:20624787
    immutable id
    pubmed:20624787@b96f9464f0ebe3440b8ad2367a0458f03746e616ec01ab6ed95a6d5c90380293
    journal
    abbreviation
    Ann Oncol
    issn electronic
    1569-8041
    issn print
    0923-7534
    issue
    2
    name
    Annals of oncology : official journal of the European Society for Medical Oncology
    nlm unique id
    9007735
    pages
    468-71
    volume
    22
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      20624787
      provenance
      batch id
      bce21fa556c206e375c2
      provider
      NCBI PubMed ESummary
      record sha256
      b9cf22461e0719a41095043b515802ea75ee2eb58bdb923bc5d05d75933695a4
      response sha256
      280642fcc56e65c443f5ee9e69c6371de9e91c70665c7390bba25595a34da323
      retrieved at
      2026-09-09T23:46:33.526275+00:00
      publication date
      display
      2011 Feb
      precision
      month
      year
      2011
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/20624787/
      title
      Efficacy of high-dose methotrexate, ifosfamide, etoposide and dexamethasone salvage therapy for recurrent or refractory childhood malignant lymphoma.

      Preserved source evidence · Not medical advice